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Patients with hematologic malignancies are susceptible to serious complications due to
immunosuppression.  Neutropenic-related infection is one of the major causes of morbidity
and  mortality in this group of diseases. Febrile neutropenia is a common complication of
the hematologic neoplasm itself or chemotherapy, and has worse prognosis if prolonged
(lasting  more than 7 days) or severe (neutrophil count below 500 cells per L). Among the
usual  sites of infection, we highlight the neutropenic enterocolitis and perianal infection as
gastrointestinal complications of greater interest to the colorectal surgeon. Although most
cases  respond to conservative treatment, a portion of patients will need surgery for complete
recovery.
©  2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda.
Tratamento  das  doenc¸as  colorretais  agudas  no  paciente  neutropênico
febril
alavras-chave:
eutropenia febril
r  e  s  u  m  o
Os pacientes com neoplasias hematológicas estão sujeitos a uma  séria de complicac¸ões
devido  à imunossupressão. Infecc¸ão  é umas das principais causas de morbidade e mor-
Este é um artigo Open Access sob a licença de CC BY-NC-NDiﬂite
anal  anal
talidade  nesse grupo de doenc¸as.  A neutropenia febril é uma  complicac¸ão  frequente da
própria  doenc¸a  onco-hematológica ou da quimioterapia, e apresenta pior prognóstico se
prolongada  (durac¸ão  acima de 7 dias) ou severa (contagem de neutróﬁlos inferior a 500
células  por microlitro). Dentre os focos de infecc¸ão  mais comuns destacamos a entero-
colite  neutropênica e a infecc¸ão  perianal como complicac¸ões  de maior interesse para o
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cirurgião colorretal. Apesar de grande parte dos casos apresentar boa resposta ao tratamento
conservador, uma parcela de pacientes necessitará de cirurgia para completa recuperac¸ão.
©  2014 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
and  (3) know the local resistance of pathogens.2,14 Cefepime,
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Neutropenia is a common ﬁnding in patients with hematolog-
ical  malignancies. It occurs as a manifestation of the disease
or  a consequence of immunosuppressive treatment.1 It is usu-
ally deﬁned as an absolute neutrophil count (ANC) of 1500 or
fewer  neutrophils per L of blood. Patients affected by acute
leukemia,  leukemic phase lymphomas, myelodisplastic syn-
dromes  and those receiving high intensity chemotherapy or
bone marrow transplantation conditioning regimens are espe-
cially prone to develop severe neutropenia deﬁned by an ANC
of  less than 500 cells/L.2
The risk of serious infection is signiﬁcantly higher if neu-
tropenia  is severe or prolonged (more than seven days) and
the  most common sites are: skin, venous catheters, dental dis-
eases, oropharynx, gums, paranasal sinuses, lungs, abdomen,
genitals  and perianal area.2 Inﬂammatory response is com-
promised  in those patients, thus few or no signs may  be found.
Sometimes  fever may  be the only complaint. In this con-
text,  the clinical condition of Febrile Neutropenia is deﬁned
as  the detection of a single oral temperature measurement
of ≥38.3 ◦C or a temperature of ≥38 ◦C sustained over a one
hour-period in the presence of an ANC ≤ 500 neutrophils/L
or an ANC that is expected to decrease to ≤500 neutrophils/L
during the next 48 h. In addition, neutropenic patients who
are  a febrile but have signs or symptoms of infection should
be  equally managed as febrile neutropenic patients. Prompt
recognition and treatment of any infectious process is crucial
since  the clinical status may  rapidly deteriorate to sepsis and
death.2
Correct evaluation of patients includes detailed anam-
nesis,  meticulous physical exams and laboratory tests to
determine  the severity of the complication and to locate
the  source of infection. Low-risk patients are those who
have  estimated neutropenia for no longer than seven days
and  no organ failures. In contrast, high-risk patients are
those  with anticipated prolonged neutropenia, profound neu-
tropenia  (ANC ≤ 100 neutrophils/L) and/or clinical conditions
such  as hypotension, pneumonia, neurological symptoms and
abdominal  pain. The index from the Multinational Associ-
ation  for Supportive Care in Cancer may  be used as a risk
assessment tool with high sensitivity and speciﬁcity.3 Of note,
all  high risk patients should be admitted to the hospital
and  receive empirical intravenous large spectrum antibiotic
therapy.2
The physician must carefully evaluate the complaint of
abdominal  pain in a neutropenic patient since it may  alert for
the occurrence of a severe gastrointestinal infection. Indeed,
signs  of peritonitis during the evaluation may  represent
complications such as typhlitis, pseudomembranous colitis
or  other causes of acute abdomen.4,5 Patients must also have
their  perianal region checked for anorectal diseases andﬂogosis. Rectal exam should not be neglected and invasive
procedures must be taken with the appropriate consideration
of  the risk of bacterial translocation and disease worsening.6
Neutropenic  enterocolitis
Classically known as typhlitis or ileocecal syndrome, neu-
tropenic  enterocolitis is a necrotizing polymicrobial colitis,
diagnosed almost exclusively in patients with neutropenia.7
The word “typhlon” means cecum in Greek, nevertheless the
terminal  ileum and the whole colon may  be also affected.
Although this condition is often described as necrotizing
enterocolitis, the clinical picture may  vary from a mild, non-
necrotizing  form, to a severe transmural process with a high
risk  of death.8
Neutropenic enterocolitis has been historically reported as
the  most common gastrointestinal complication in patients
with  fever, neutropenia and abdominal pain, affecting as
much  as 50% of such patients, which mortality rates that vary
from  20 to 50%.9,10
The genesis of this complication waits for complete
understanding, however some factors may  be involved:
chemotherapy cytotoxic effects, damage of gut mucosa,
immunosuppression and translocation of virulent microor-
ganisms.  The pathologic result is gangrenous necrosis,
subserosal gas accumulation and perforation of the affected
segment,  due to intestinal infarction.4
The diagnosis of typhlitis should be presumed in patients
with  severe neutropenia, abdominal pain (right lower quad-
rant)  and fever. Physical exam may  evidence abdominal
distention and tenderness. Differential diagnosis includes
acute  appendicitis, psoas abscess and pseudomembranous
colitis.5,11 Computed tomography usually seals the diagnosis
by  revealing thick and dilated bowel walls with mesen-
teric stranding.12 Plain ﬁlms of the abdomen can be used
to  detect pneumoperitoneum. Invasive procedures such as
colonoscopy  and barium enema may  cause bowel perfora-
tion  and should not be attempted. A ﬂexible sigmoidoscopy
and C. difﬁcile assays may  be necessary to rule out pseu-
domembranous colitis in a patient with important diarrhea
associated to abdominal distention and recent history of
antibiotic  therapy.13
Medical treatment of uncomplicated typhlitis consists of
broad-spectrum antibiotics, bowel rest, nasogastric suction,
hydroeletrolitic adjustment and anemia correction (Fig. 1). To
choose the right empiric antibiotic regimen, the physician
must: (1) consider the polymicrobial nature of the infection;
(2)  evaluate the patient’s risk factors for complicated outcome;a  fourth generation cephalosporin, is the ﬁrst option in our
institution. If resistant gram-negative bacteria infection is
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1. Bowel rest
2. Nasogastric suction
3. Parenteral nutrition
4. Hydroeletrolitic adjustment
5. Correction of cytopenias and 
    coagulopathy
6. Broad spectrum antibiotic therapy
Medical management
Unstable PatientStable Patient
Hemorrhage
Hemodynamic instability
Pneumoperitoneum
No improvement to medical therapy
Laparotomy
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9. Gorschlüter M, Mey U, Strehl J, Ziske C, Schepke M,Fig. 1 – Neutropenic enterocolitis management.
uspected either by blood cultures or previous patient’s colo-
ization,  the addition of an aminoglycoside is recommended.
he  use of a carbapenem or piperacillin-tazobactam is also
cceptable  as ﬁrst line therapy. Metronidazole or vancomycin
hould  be added for suspected C. difﬁcile infection. The use of
ntifungal  therapy can be also advised in individual cases with
ersistent  and long-term neutropenia and refractoriness to
he antibacterial agent. Finally, supportive care with transfu-
ions  to improve anemia, thrombocytopenia and coagulation
efects  as well as the use of granulocyte stimulating factors
r  granulocyte infusions should be also be considered and
ndividualized to each patient.
The disease is considered as complicated in the presence
f  bowel perforation with peritonitis, gastrointestinal hemor-
hage  or deterioration of the clinical status (such as sepsis or
rgan  perfusion impairment). For those cases, surgery is the
nly  option and patient’s life depends on the ability of the sur-
eon  to identify and remove all devitalized tissue.15 Usually, a
ight hemicolectomy with a terminal ileostomy and mucous
stula  appears to be a reasonable option given the serious
ature  of the disease at this point.16
norectal  diseases
eutropenic patients are susceptible to any anorectal disease.
erianal  infection (represented by an abscess or infected ﬁs-
ula)  is the most feared complication, considering the lack
f  natural defense against infectious microorganisms. Man-
festations  may  differ from those with a competent immune
ystem  and include mild to severe anorectal pain, fever and a
oorly deﬁned induration of the anal canal. Perianal infection
s  a life-threatening complication that requires ready diagno-
is  and intervention as recurrence and mortality rates may  be
xpressive.17 In a series of 92 patients with acute or chronic
eukemia, the most common manifestations were perirectal
bscess  (27%), followed by anal ﬁssures (23%), external hem-
rrhoids  (19%) and perianal ulcerations (13%). Only 16% of the
atients  required surgery most commonly to drain perirec-
al  abscesses.18 Another retrospective study of 1102 patients
ound  a perianal infection prevalence of 6.7%. Recurrence was
iagnosed  in 31% of the cases and 34% of the patients received
urgical  intervention.19Conservative measures consist of systemic antibiotics, sitz
aths,  stool softeners and proper anal hygiene. Spectrum of
ntibiotic  coverage should be broad given the polymicrobial;3 4(3):189–192  191
nature of the Infection. In a review of 963 cases of bone
marrow transplantation, the most common microorganisms
were Escherichia coli, Bacteroides, Enterococcus, and Klebsiella.20
Surgery harbors the risks of uncontrolled bleeding and poor
healing  but may  be the only choice for abscesses and ﬁstulas.
If  any operation is to be considered, common sense dictates
the  decision on holding the chemotherapy.
Conclusions
Patients with neutropenia are predisposed to a variety of
infectious  diseases. Prompt recognition and early treatment
of  such complications are essential for survival. Much  atten-
tion  should be paid to the abdomen, perineum and anorectal
area,  since they can be the sites of infection. The diagnosis
of  neutropenic enterocolitis, anorectal abscesses, or ﬁstulas
requires  immediate consultation with a colorectal surgeon,
even  though medical management may  be sufﬁcient for a
signiﬁcant  portion of cases. In the presence of uncontrolled
sepsis, bowel wall perforation, continuous gastrointestinal
hemorrhage, surgery becomes the last resource and life will
depend  on the surgeon’s knife.
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